Big Pharma vs SPY: returns, Sharpe ratio and drawdown
Performance
Big Pharma+25.13%SPY+11.82%
Summary
Big Pharma vs SPY
Over the past year, Big Pharma returned more: +25.13% against +11.82% for SPY. Over five years, Big Pharma returned more: +15.45% a year against +10.77% for SPY. Big Pharma had the higher Sharpe ratio over the past year (1.04 vs 0.62), meaning more return for each unit of volatility. SPY fell less at its worst over the past year: -8.88% from its peak, against -9.77% for Big Pharma. Their daily returns had a correlation of 0.20 over the past year, which is low and below the 0.35 of the past five years (measured on weekly returns).
Ranking
How Big Pharma and SPY rank
Big PharmaSPY
8965
1Y Return Rank8279
5Y Return Rank7668
Sharpe Ratio Rank3563
Max Drawdown Rank2661
Volatility Rank—28
Dividend Yield RankCurrent Drawdown
Big Pharma-5.01%SPY-6.28%
Rolling Volatility
Big Pharma23.74%SPY21.93%
METRICS
Correlation Matrix
Assets
Allocation
Big Pharma
SPY
Metrics
Risk Indicators
Big PharmaSPY
Alpha
Big Pharma
18.40%
SPY
0.00%
Beta
Big Pharma
0.29x
SPY
1.00x
Sharpe
Big Pharma
1.04
SPY
0.62
Sortino
Big Pharma
1.64
SPY
0.86
Omega
Big Pharma
1.18
SPY
1.11
Calmar
Big Pharma
2.57
SPY
1.33
Martin
Big Pharma
4.91
SPY
3.73